{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0090303",
      "entity_text" : "injury",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00890",
      "entity_text" : "anti-TNF-alpha antibody",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Application of anti-TNF-alpha antibody or TNF-alpha antagonist etanercept in animal AP model can significantly reduce serum amylase and lipase, relieve the degree of pancreas and associate-lung injury, and improve animal survival rate 24.",
  "reading_complete" : "2020-08-05T19:34:05Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T19:32:46Z",
  "trigger" : "relieve",
  "evidence" : [ "anti-TNF-alpha antibody or TNF-alpha antagonist etanercept in animal AP model can significantly reduce serum amylase and lipase, relieve the degree of pancreas and associate-lung injury" ],
  "pmc_id" : "6705337",
  "score" : 0
}